Aquinnah Pharmaceuticals receives $3.4 million grant from NINDS to advance new therapies for ALS
Credit: © Aquinnah Pharmaceuticals CAMBRIDGE, Mass. -- June 20, 2018 -- Aquinnah Pharmaceuticals, leaders in stress granule biology, an exciting new target for the development...